A molecular basis for resistance to liver damage from transfusional iron overload in sickle cell disease.

被引:0
|
作者
Hagar, W
Harmatz, P
Vichinsky, EP
Theil, EC
机构
[1] Childrens Hosp, Oakland Res Inst, Ctr BioIron, Oakland, CA 94609 USA
[2] Childrens Hosp & Res Ctr, Oakland, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2627
引用
收藏
页码:668A / 668A
页数:1
相关论文
共 50 条
  • [41] Dietary supplementation with sulforaphane attenuates liver damage and heme overload in a sickle cell disease murine model
    Panda, Harit
    Keleku-Lukwete, Nadine
    Kuga, Ayumi
    Fuke, Nobuo
    Suganuma, Hiroyuki
    Suzuki, Mikiko
    Yamamoto, Masayuki
    EXPERIMENTAL HEMATOLOGY, 2019, 77 : 51 - 60
  • [42] The labile iron pool of erythrocytes is decreased in sickle cell disease.
    Darbari, DS
    Loyevsky, M
    Rana, SR
    Castro, OL
    Gordeuk, VR
    Kurantsin-Mills, J
    BLOOD, 2001, 98 (11) : 4B - 4B
  • [43] ADULT PATIENTS WITH SICKLE-CELL-ANEMIA AND TRANSFUSIONAL IRON OVERLOAD DO NOT HAVE IMPAIRED RENAL-FUNCTION
    SIEGEL, RS
    GORDEUK, VR
    BLOOD, 1994, 84 (10) : A558 - A558
  • [44] Plasma Biomarkers of Iron Regulation, Overload, and Inflammation in Sickle Cell Disease
    Mangaonkar, Abhishek
    Patel, Niren
    Xu, Hongyan
    Natrajan, Kavita
    Clair, Betsy
    Wells, Leigh G.
    Bowman, Latanya
    Barret, Nadine
    Kutlar, Abdullah
    BLOOD, 2014, 124 (21)
  • [45] Cardiovascular evaluation and management of iron overload cardiomyopathy in sickle cell disease
    Ginwalla, Mahazarin
    AlMasoud, Abdullah
    Tofovic, David
    Alin, Tara
    Al-Kindi, Sadeer
    Oliveira, Guilherme
    Rajagopalan, Sanjay
    Schilz, Robert
    Little, Jane
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) : E7 - +
  • [46] Clinical Impact of Iron Overload on Morbidity in Patients with Sickle Cell Disease
    Shrestha, Anuj
    Grover, Punita
    Ahmed, Zaheer
    Singh, Daulath
    Arora, Simran
    Manthravadi, Sashidhar
    Moormeier, Jill
    Cheng, Anlin
    Music-Aplenc, Lejla
    Madhusudhana, Sheshadri
    BLOOD, 2017, 130
  • [47] IRON OVERLOAD AND DISSEMINATED MAC IN A PEDIATRIC PATIENT WITH SICKLE CELL DISEASE
    Strumph, Kaitlin
    Morrone, Kerry
    Boruchov, Donna
    Bezler, Natalie
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [48] BIO-MARKERS OF IRON TRAFFICKING AND DISTRIBUTION IN TRANSFUSIONAL OVERLOAD: INSIGHTS FROM COMPARING DIOND BLACKFAN ANEMIA WITH SICKLE CELL DISEASE AND THALASSEMIA (MCSIO PILOT STUDY)
    Porter, John
    Walter, Patrick
    Neumayr, Lynne
    Evans, Patricia
    Weyhmiller, Marcela
    Harmatz, Paul
    Wood, John
    Miller, Jeff
    Weiss, Guenter
    Yuan, Quing
    Wang, Zhiyue
    Grosse, Regine
    Schoennagel, Bjoern
    Meerpohl, Joerg
    Fischer, Roland
    Nielsen, Peter
    Seifert, Markus
    Vichinsky, Elliott
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E46 - E47
  • [49] Iron Overload and Treatment Outcome in an Adult Sickle Cell Disease Cohort
    Njoku, Franklin
    Farooqui, Marwah
    Rizvi, Insia
    Han, Jin
    Molokie, Robert
    Saraf, Santosh L.
    Gordeuk, Victor R.
    BLOOD, 2023, 142
  • [50] Two-Year Analysis of Efficacy and Safety of Deferasirox Treatment for Transfusional Iron Overload in Sickle Cell Anemia Patients
    Cancado, Rodolfo
    Olivato, Maria Cristina A.
    Bruniera, Paula
    Szarf, Gilberto
    Bastos, Roberto de Moraes
    Melo, Murilo Rezende
    Chiattone, Carlos
    ACTA HAEMATOLOGICA, 2012, 128 (02) : 113 - 118